mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.1 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.1 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.1 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.087 |
0.1 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.1 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.1 |